Zhejiang Huahai Pharmaceutical Co Ltd (600521) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Zhejiang Huahai Pharmaceutical Co Ltd (600521) has a cash flow conversion efficiency ratio of 0.029x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥282.81 Million ≈ $41.38 Million USD) by net assets (CN¥9.60 Billion ≈ $1.40 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Zhejiang Huahai Pharmaceutical Co Ltd (600521) total market value for the company's overall valuation and market capitalisation.
Zhejiang Huahai Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2001–2025)
This chart illustrates how Zhejiang Huahai Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Zhejiang Huahai Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang Huahai Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore cash flow quality index of Zhejiang Huahai Pharmaceutical Co Ltd to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Palomar Holdings Inc
NASDAQ:PLMR
|
0.095x |
|
PTT OIL+RET.BUS.-NVDR- 10
F:7F80
|
0.185x |
|
Shaanxi Sirui Advanced Materials Co. Ltd. A
SHG:688102
|
N/A |
|
Fielmann Aktiengesellschaft
XETRA:FIE
|
0.243x |
|
Cal-Maine Foods Inc
NASDAQ:CALM
|
0.002x |
|
Hoegh Autoliners ASA
OL:HAUTO
|
0.458x |
|
Uni-President China Holdings Ltd
F:58U
|
0.031x |
|
AXIA Energia
NYSE:AXIA
|
0.039x |
Annual Cash Flow Conversion Efficiency for Zhejiang Huahai Pharmaceutical Co Ltd (2001–2025)
The table below shows the annual cash flow conversion efficiency of Zhejiang Huahai Pharmaceutical Co Ltd from 2001 to 2025. View 600521 live share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥9.46 Billion ≈ $1.38 Billion |
CN¥1.23 Billion ≈ $180.00 Million |
0.130x | -45.99% |
| 2024-12-31 | CN¥9.02 Billion ≈ $1.32 Billion |
CN¥2.17 Billion ≈ $317.93 Million |
0.241x | -10.35% |
| 2023-12-31 | CN¥8.25 Billion ≈ $1.21 Billion |
CN¥2.22 Billion ≈ $324.42 Million |
0.269x | +67.47% |
| 2022-12-31 | CN¥7.75 Billion ≈ $1.13 Billion |
CN¥1.24 Billion ≈ $181.85 Million |
0.160x | +15.85% |
| 2021-12-31 | CN¥6.78 Billion ≈ $991.59 Million |
CN¥938.43 Million ≈ $137.32 Million |
0.138x | -40.13% |
| 2020-12-31 | CN¥6.72 Billion ≈ $983.95 Million |
CN¥1.56 Billion ≈ $227.61 Million |
0.231x | -23.78% |
| 2019-12-31 | CN¥5.78 Billion ≈ $845.61 Million |
CN¥1.75 Billion ≈ $256.66 Million |
0.304x | +1780.57% |
| 2018-12-31 | CN¥4.21 Billion ≈ $615.58 Million |
CN¥67.90 Million ≈ $9.94 Million |
0.016x | -85.06% |
| 2017-12-31 | CN¥5.05 Billion ≈ $739.67 Million |
CN¥546.24 Million ≈ $79.93 Million |
0.108x | +14.22% |
| 2016-12-31 | CN¥4.58 Billion ≈ $669.88 Million |
CN¥433.10 Million ≈ $63.38 Million |
0.095x | +80.21% |
| 2015-12-31 | CN¥3.72 Billion ≈ $544.40 Million |
CN¥195.31 Million ≈ $28.58 Million |
0.052x | -47.82% |
| 2014-12-31 | CN¥3.27 Billion ≈ $477.93 Million |
CN¥328.61 Million ≈ $48.09 Million |
0.101x | -38.04% |
| 2013-12-31 | CN¥3.02 Billion ≈ $441.82 Million |
CN¥490.29 Million ≈ $71.75 Million |
0.162x | +29.80% |
| 2012-12-31 | CN¥1.95 Billion ≈ $285.21 Million |
CN¥243.83 Million ≈ $35.68 Million |
0.125x | -3.12% |
| 2011-12-31 | CN¥1.53 Billion ≈ $223.82 Million |
CN¥197.51 Million ≈ $28.90 Million |
0.129x | -43.15% |
| 2010-12-31 | CN¥1.32 Billion ≈ $192.92 Million |
CN¥299.47 Million ≈ $43.82 Million |
0.227x | -13.25% |
| 2009-12-31 | CN¥1.21 Billion ≈ $177.39 Million |
CN¥317.44 Million ≈ $46.45 Million |
0.262x | +243.02% |
| 2008-12-31 | CN¥1.10 Billion ≈ $161.41 Million |
CN¥84.20 Million ≈ $12.32 Million |
0.076x | -45.45% |
| 2007-12-31 | CN¥975.52 Million ≈ $142.75 Million |
CN¥136.52 Million ≈ $19.98 Million |
0.140x | +57.99% |
| 2006-12-31 | CN¥875.40 Million ≈ $128.10 Million |
CN¥77.54 Million ≈ $11.35 Million |
0.089x | +33.34% |
| 2005-12-31 | CN¥802.34 Million ≈ $117.41 Million |
CN¥53.30 Million ≈ $7.80 Million |
0.066x | -68.13% |
| 2004-12-31 | CN¥785.53 Million ≈ $114.95 Million |
CN¥163.73 Million ≈ $23.96 Million |
0.208x | +201.31% |
| 2003-12-31 | CN¥685.42 Million ≈ $100.30 Million |
CN¥47.41 Million ≈ $6.94 Million |
0.069x | -92.60% |
| 2002-12-31 | CN¥80.56 Million ≈ $11.79 Million |
CN¥75.34 Million ≈ $11.02 Million |
0.935x | +79.90% |
| 2001-12-31 | CN¥72.15 Million ≈ $10.56 Million |
CN¥37.51 Million ≈ $5.49 Million |
0.520x | -- |
About Zhejiang Huahai Pharmaceutical Co Ltd
Zhejiang Huahai Pharmaceutical Co., Ltd. engaged in the research, development, production, and sales of generic drugs, biologics, drugs, and specialty active pharmaceutical ingredients in multiple dosage forms in China and internationally. The company offers central neurological, cardiovascular, anti-viral, and other products, as well as APIs and intermediates. It also provides packaging componen… Read more